Transaction DateRecipientSharesTypePriceValue
22nd December 2020Management Inc. Opaleye496,277Open or private purchase$8.06$3,999,992.62
22nd December 2020Management Inc. Opaleye657Open or private purchase$5.19$3,412.98
22nd December 2020Management Inc. Opaleye15,900Open or private purchase$5.19$82,597.32
21st December 2020Management Inc. Opaleye51,400Open or private purchase$5.24$269,305.16
21st December 2020Management Inc. Opaleye2,059Open or private purchase$5.24$10,787.92
18th December 2020Management Inc. Opaleye35,000Open or private purchase$5.31$185,941.00
18th December 2020Management Inc. Opaleye1,400Open or private purchase$5.31$7,437.64
21st October 2020Management Inc. Opaleye3,000Open or private purchase$4.40$13,190.70
21st October 2020Management Inc. Opaleye5,656Open or private purchase$4.40$24,868.87
16th October 2020Management Inc. Opaleye385,000Open or private purchase$7.00$2,695,000.00
Harrow Health
Harrow Health logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.



Ticker: HROW
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1360214
Employees:
Exchange:
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Inventory, Net: $4 M (0%)
Other Assets, Current: $89 Th (-15%)
Assets, Current: $30 M (-17%)
Property, Plant and Equipment, Net: $5 M (0%)
Assets: $49 M (-16%)
Liabilities, Current: $13 M (6%)
Liabilities: $34 M (7%)
Common Stock, Value, Issued: $26 Th (0%)
Common Stock, Shares, Issued: $26 M (0%)
Retained Earnings (Accumulated Deficit): $87 M (17%)
Stockholders' Equity (Parent): $16 M (-43%)
Liabilities and Equity: $49 M (-16%)
Revenue: $8 M (0%)
Cost of Revenue: $3 M (-53%)
Gross Margin: $5 M (-62%)
Research and Development: $749 Th (-34%)
Operating Income/Loss: $3 M (-16%)
Other Income, net: $3 M (-68%)
EPS (basic): $0.01 (0%)
EPS (diluted): $0.01 (0%)